The global polymyxin resistance testing market is projected to experience remarkable growth over the next decade, driven by the increasing prevalence of multidrug-resistant Gram-negative bacterial infections. Valued at USD 122.0 million in 2023, the market is anticipated to expand at a compound annual growth rate (CAGR) of 6.2%, reaching USD 222.5 million by 2033.
The emergence and spread of polymyxin-resistant bacteria, particularly due to the production of enzymes called carbapenemases, have raised concerns in healthcare settings. Effective detection and monitoring of polymyxin resistance are crucial to guide appropriate treatment decisions and prevent the further spread of resistant strains.
The Polymyxin Resistance Testing market primarily consists of diagnostic tests and products designed to identify the presence of polymyxin resistance genes or enzymes in bacterial isolates. These tests help healthcare providers determine whether a particular strain of bacteria is susceptible or resistant to polymyxin antibiotics.
Antibiotic treatment individualized based on patient characteristics, including resistance profiles, is becoming more popular. Testing for polymyxin resistance enables medical professionals to choose the best antibiotic therapy with knowledge.
Diagnostic firms, molecular testing labs, and university research organizations are significant market participants in the polymyxin resistance testing industry. These businesses create and distribute a variety of test kits, reagents, and platforms for determining polymyxin resistance.
It’s crucial to keep in mind that the market for polymyxin resistance testing falls under the category of infectious disease diagnostics, which is somewhat specialized and may have a smaller market than areas like molecular diagnostics or testing for antibiotic susceptibility.
Key Takeaways from the Polymyxin Resistance Testing Market:
- The polymyxin resistance testing industry in the United States is predicted to reach USD 56.1 million by 2033, increasing at a 6.2% CAGR.
- The polymyxin resistance testing industry in the United Kingdom is estimated to reach a market value of USD 7.4 million, expanding at a CAGR of 4.8% by 2033.
- During the forecast period, the polymyxin resistance testing industry in China is expected to reach a market value of USD 19.0 million, securing a 7.5% CAGR.
- The polymyxin resistance testing industry in Japan is predicted to reach USD 13.3 million by 2033, increasing at a 7.1% CAGR.
- South Korea’s polymyxin resistance testing industry is predicted to achieve a market value of USD 5.6 million, rising at a 6.6% CAGR during the forecast period.
- With a CAGR of 6.4% from 2023 to 2033, the testing systems segment is expected to dominate the polymyxin resistance testing industry.
- With a CAGR of 6.4% from 2023 to 2033, the polymerase chain reaction (PCR) are expected to dominate the polymyxin resistance testing industry.
- With a CAGR of 7.0% from 2023 to 2033, the academic & research institutions is expected to dominate the polymyxin resistance testing industry.
Accelerated Market Demand: Find Comprehensive Insights and Trends in Our Full Report!
How Does the Competition Look in the Polymyxin Resistance Testing Market?
The polymyxin resistance testing sector is a very competitive with active players like Thermofisher Scientific, Mast Group, Liofilchem, Rosco Diagnostica A/S, bioMérieux SA, Meridian, Beckman Coulter, Becton Dickenson & Company, Accelerate Diagnostics, Inc., Bruker, EUCAST, Generon S.p.A., and Bio-Rad Laboratories.
The main corporations are investing extensively in research and development efforts to develop inventive and creative products with improved reliability, efficacy, and cost. In order to meet changing consumer expectations, they are also concentrating on growing their product line and bolstering their distribution strategies.
Industry-wide, tactical alliances and partnerships with other businesses are more frequent, enabling parties to capitalize on one another’s advantages and increase their market power.
Leading companies employ mergers and consolidation to expand into new markets and improve their market share. In emerging markets, particularly in China and India, the sector is rapidly growing.
Major corporations are developing regional production facilities and increasing their distribution networks to increase their presence in these areas. In order to gain a competitive edge, they are also focusing on providing clients in these markets with cost-effective solutions.
Key Developments in the Polymyxin Resistance Testing Market:
- In June 2019, Thermo Fisher Scientific launches automated system for antimicrobial susceptibility testing in Europe
- In April 2022, Through its purchase of Specialised Diagnostic (San Jose, CA, USA), which focuses on quick AST solutions, bioMérieux has increased its commitment to combat AMR. A fast AST device that delivers phenotypic AST immediately from positive blood cultures was created by Specific.
Segmentation Analysis of the Polymyxin Resistance Testing Market:
By Product:
- Testing Systems
- Test Kits & Identification Panels
- Reagents & Consumables
By Testing Methods:
- Broth Microdilution (BMD)
- Disk Diffusion
- Etest (Broth Microdilution + Disk Diffusion)
- Polymerase Chain Reaction (PCR)
By End User:
- Clinical Laboratories
- Academic & Research Institutions
- Pharmaceutical/Biotech Companies
- Food & Environmental Testing Laboratories
- Veterinary Diagnostic Laboratories
By Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- The Middle East & Africa
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
